Exparel PK and Breast Milk Excretion

Milk Expression, Breast Clinical Trial

Official title:
Pharmacokinetics and Breast Milk Excretion of Liposomal Bupivacaine After TAP Block in Patients Undergoing Cesarean Section Delivery

Status Completed

Clinical Trial Summary

Investigate the pharmacokinetics of Liposomal Bupivacaine and its excretion in breast milk in patients undergoing TAP block after their scheduled C -section delivery

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Milk Expression, Breast

Clinical Trial Details

NCT number	NCT03526419
Study type	Observational
Source	University of Minnesota - Clinical and Translational Science Institute
Contact
Status	Completed
Phase
Start date	February 1, 2019
Completion date	September 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04929301` - Antenatal Milk Expression in Nulliparous Pregnant People	N/A
Recruiting	`NCT04447742` - Bern Birth Cohort / Trajectory of Microbiota Maturation in Healthy Bern Infants - a Network Approach
Completed	`NCT03568851` - Reproductive Health Outcomes by Method of Breast Milk Feeding
Not yet recruiting	`NCT06182449` - Virtual Reality Distraction for Maternal Milk Expression (PILOT)	N/A
Completed	`NCT05390372` - Efficacy of Breast Milk in Healing of Skin Damage	N/A